Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’

Опубликовано: 09 Декабрь 2023
на канале: PBS NewsHour

9,935

198

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: / newshour
Instagram: / newshour

Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe

Смотрите видео Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’ онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь PBS NewsHour 09 Декабрь 2023, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 9,935 раз и оно понравилось 198 людям.